| Authors: |
Moura LI; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal., Malfanti A; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, Padova, 35131, Italy., Matos AI; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal., Peres C; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal., Armiñán A; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain., Duro-Castaño A; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Curapath, Av. Benjamin Franklin 19, Paterna, 46980, Spain., Conejos-Sánchez I; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain., Medel M; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain., Đorđević S; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain.; Tosoh Bioscience GmbH, Im Leuschnerpark 4, Griesheim, 64347, Hesse, Germany., Carrascosa P; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain., Carreira B; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal., Acúrcio RC; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal., Xavier-Ferreira H; i3S - Instituto de Investigação e Inovação em Saúde, Medical Faculty of Porto, Universidade do Porto, Rua Alfredo Allen, 208, Porto, 4200-135, Portugal., Hernández-Barranco A; Microenvironment and Metastasis Laboratory, Department of Molecular Oncology, Spanish National Cancer Research Center (CNIO), C. de Melchor Fernández Almagro, 3, Madrid, 28029, Spain., Castellano E; Microenvironment and Metastasis Laboratory, Department of Molecular Oncology, Spanish National Cancer Research Center (CNIO), C. de Melchor Fernández Almagro, 3, Madrid, 28029, Spain., Roselló E; Department of Pathology, Hospital General Universitario de Valencia, Av. de les Tres Creus, 2, L'Olivereta, Valencia, 46014, Spain., Machado JC; i3S - Instituto de Investigação e Inovação em Saúde, Medical Faculty of Porto, Universidade do Porto, Rua Alfredo Allen, 208, Porto, 4200-135, Portugal., Peinado H; Microenvironment and Metastasis Laboratory, Department of Molecular Oncology, Spanish National Cancer Research Center (CNIO), C. de Melchor Fernández Almagro, 3, Madrid, 28029, Spain., Vicent MJ; Polymer Therapeutics Lab, Prince Felipe Research Center (CIPF), C/Eduardo Primo Yúfera 3, Valencia, 46012, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain., Florindo HF; Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisboa, 1649-003, Portugal.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Health Institute Carlos III (IISCIII), Av. Monforte de Lemos, 3-5. Pabellón 11. Planta 0, Madrid, 28029, Spain. |
